Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Oligomeric proanthocyanidins (OPCs) are polyphenolic compounds found in many plants, including grapes, cocoa, pine bark, and certain berries. There is a moderate level of scientific evidence supporting their use in supporting cardiovascular health, though more large-scale randomized controlled trials are still needed for definitive recommendations.

OPCs are noted for their strong antioxidant properties, which help protect blood vessels from oxidative damage and reduce inflammation. Clinical studies have shown that OPCs may improve endothelial function, lower blood pressure, and reduce LDL oxidation, which are all relevant to cardiovascular disease risk. For example, a meta-analysis published in the American Journal of Clinical Nutrition (2016) concluded that flavonoid-rich supplements, including those high in OPCs, produced modest but significant reductions in systolic and diastolic blood pressure. Other trials have found that OPCs from grape seed extract can improve markers of vascular health in individuals with metabolic syndrome or high cardiovascular risk.

Despite these promising findings, the evidence base is not yet robust enough to recommend OPCs as a primary therapy for cardiovascular disease. Most studies are of short duration, involve small sample sizes, and use varying doses and sources of OPCs. However, the existing scientific literature does suggest a potential cardioprotective benefit when used as part of a broader lifestyle and treatment strategy.

More about Oligomeric proanthocyanidins
More about Cardiovascular Disease

Other ingredients used for Cardiovascular Disease

Other health conditions supported by Oligomeric proanthocyanidins

Products containing Oligomeric proanthocyanidins